Alternative single anticonvulsant drug therapy for refractory epilepsy

Area of Science:

• Neurology
• Clinical Pharmacology

Background:

• Chronic epilepsy often presents with seizures refractory to initial monotherapy.
• Primary anticonvulsant drugs like carbamazepine, phenytoin, phenobarbital, and primidone are common first-line treatments.

Purpose of the Study:

• To evaluate the efficacy of alternative single-drug therapy in patients with chronic refractory epilepsy.
• To determine if switching to a different primary anticonvulsant improves seizure control and reduces side effects.

Main Methods:

• A cohort of 59 patients with refractory epilepsy received alternative single-drug therapy with one of four primary anticonvulsants.
• Patients had previously failed maximally tolerated doses of another drug from the same class.

Main Results:

• Alternative single-drug therapy achieved complete seizure control or >75% reduction in 18 patients (31%).
• Side effects resolved in 16 patients (27%).
• A positive therapeutic response was more common in patients with recent-onset epilepsy.

Conclusions:

• Alternative single-drug therapy is a viable and beneficial strategy for managing chronic refractory epilepsy.
• This approach should be considered before adding a second anticonvulsant medication.